medigraphic.com
ISSN 0035-0052 (Impreso)

2018, Número 2

<< Anterior Siguiente >>

Rev Mex Pediatr 2018; 85 (2)


Chikungunya en niños: emergencia de una nueva enfermedad en Sonora, México. Presentación de seis casos clínicos

Gómez-Rivera N, Gómez-Jiménez IA, Alomía-Zegarra JL, Fonseca-Chon I, García-Zárate MG, Gómez-Figueroa CO, Villalobos-García L

Idioma: Español
Referencias bibliográficas: 32
Paginas: 66-69
Archivo PDF: 216.64 Kb.


RESUMEN

Objetivo: Describir las características clínicas y de laboratorio de la enfermedad exantemática por virus de chikungunya (CHIKV). Material y métodos: Revisión de expedientes clínicos con diagnóstico de CHIKV ocurridos en el Hospital Infantil del Estado de Sonora durante el año 2015. Resultados: Cinco casos se resolvieron sin complicaciones en la fase aguda y un caso desarrolló artritis y artralgias con tres meses de evolución sin secuelas ortopédicas. Un caso con trombocitopenia leve, cuatro niños desarrollaron linfopenia y un caso con neutropenia, leucopenia y linfopenia. Conclusiones: Los seis casos mostraron una evolución favorable, ningún niño presentó encorvamiento por dolor, rasgo característico de la enfermedad, ni secuelas posteriores.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Barrett A, Weaver S. Arboviruses: alphaviruses, flaviviruses and bunyaviruses. Medical Microbiology. Churchill Livingstone; 2002. pp. 484-501.

  2. Staples JE, Fischer M. Chikungunya virus in the Americas--what a vector borne pathogen can do. N Engl J Med. 2014; 371(10): 887-889.

  3. Vu DM, Jungkind D, Angelle-Desiree L. Chikungunya virus. Clin Lab Med. 2017; 37(2): 371-382.

  4. Halstead S, Feigin R, Cherry J, Demmler G. Textbook of pediatric infectious diseases. Philadelphia: Saunders; 2004. pp. 2178-2184.

  5. Weaver SC, Lecuit M. Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med. 2015; 372(13): 1231-1239.

  6. Vasconcelos PF, Calisher C. Emergence of human arboviral diseases in the Americas, 2000-2016. Vector Borne Zoonotic Dis. 2016; 16(5): 295-301.

  7. Ramful D, Carbonnier M, Pasquet M, Bouhmani B, Ghazouani J, Noormahomed T et al. Mother-to-child transmission of Chikungunya virus infection. Pediatr Infect Dis J. 2007; 26(9): 811-815.

  8. Ramful D, Sampériz S, Fritel X, Michault A, Jaffar-Bandjee MC, Rollot O et al. Antibody kinetics in infants exposed to Chikungunya virus infection during pregnancy reveals absence of congenital infection. J Infect Dis. 2014; 209(11): 1726-1730.

  9. Rosario V, Munoz-Louis R, Valdez T, Adames S, Medrano J, Paulino I et al. Chikungunya infection in the general population and in patients with rheumatoid arthritis on biological therapy. Clin Rheumatol. 2015; 34(7): 1285-1287.

  10. Robin S, Ramful D, Le Seach’ F, Jaffar-Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol. 2008; 23(9): 1028-1035.

  11. Méndez-Domínguez N, Achach-Asaf JA, Basso-García LM, Quiñones-Pacheco YB, Gómez-Carro S. Choque séptico secundario a fiebre por chikungunya no congénita en un lactante menor: caso clínico. Rev Chil Pediatr. 2016; 87(2): 143-147.

  12. Sebastian MR, Lodha R, Kabra SK. Chikungunya infection in children. Indian J Pediatr. 2009; 76(2): 185-189.

  13. Valamparampil JJ, Chirakkarot S, Letha S, Jayakumar C, Gopinathan KM. Clinical profile of Chikungunya in infants. Indian J Pediatr. 2009; 76(2): 151-155.

  14. Mourya DT, Yadav P. Vector biology of dengue & chikungunya viruses. Indian J Med Res. 2006; 124(5): 475-480.

  15. Crosby L, Perreau C, Madeux B, Cossic J, Armand C, Herrmann-Storke C et al. Severe manifestations of chikungunya virus in critically ill patients during the 2013-2014 Caribbean outbreak. Int J Infect Dis. 2016; 48: 78-80.

  16. Jadhav M, Namboodripad M, Carman RH, Carey DE, Myers RM. Chikungunya disease in infants and children in Vellore: a report of clinical and haematological features of virologically proved cases. Indian J Med Res. 1965; 53(8): 764-776.

  17. Mercado M, Acosta-Reyes J, Parra E, Pardo L, Rico A, Campo A et al. Clinical and histopathological features of fatal cases with dengue and chikungunya virus co-infection in Colombia, 2014 to 2015. Euro Surveill. 2016; 21(22). doi: 10.2807/1560-7917.ES.2016.21.22.30244.

  18. Galindo-Fraga A, Ochoa-Hein E, Sifuentes-Osornio J, Ruiz-Palacios G. Zika virus: a new epidemic on our doorstep. Rev Invest Clin. 2015; 67(6): 329-332.

  19. Kantor IN. Dengue, zika and chikungunya. Medicina (B Aires). 2016; 76(2): 93-97.

  20. Ali Ou Alla S, Combe B. Arthritis after infection with Chikungunya virus. Best Pract Res Clin Rheumatol. 2011; 25(3): 337-346.

  21. Miner JJ, Aw-Yeang HX, Fox JM, Taffner S, Malkova ON, Oh ST et al. Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol. 2015; 67(5): 1214-1220.

  22. Raghavendhar BS, Ray P, Ratagiri VH, Sharma BS, Kabra SK, Lodha R. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study. J Med Virol. 2016; 88(6): 923-930.

  23. Gómez-Rivera N, Mada-Velez JG. Brote de dengue en población pediátrica. 530 casos. Bol Clin Infant Edo Son. 1998; 15: 71-76.

  24. Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine. 2009; 76(6): 654-657.

  25. Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg. 1969; 18(6): 954-971.

  26. Carbajo AE, Vezzani D. Waiting for chikungunya fever in Argentina: spatio-temporal risk maps. Mem Inst Oswaldo Cruz. 2015; 110(2): 259-262.

  27. Taraphdar D, Sarkar A, Mukhopadhyay BB, Chatterjee S. A comparative study of clinical features between monotypic and dual infection cases with Chikungunya virus and dengue virus in West Bengal, India. Am J Trop Med Hyg. 2012; 86(4): 720-723.

  28. Thiberville SD, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould EA, Roques P et al. Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res. 2013; 99(3): 345-370.

  29. Chen MW, Tan YB, Zheng J, Zhao Y, Lim BT, Cornvik T et al. Chikungunya virus nsP4 RNA-dependent RNA polymerase core domain displays detergent-sensitive primer extension and terminal adenylyltransferase activities. Antiviral Res. 2017; 143: 38-47.

  30. Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O, Quenel P et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion. Epidemiol Infect. 2009; 137(4): 534-541.

  31. Rothan HA, Bahrani H, Abdulrahman AY, Mohamed Z, Teoh TC, Othman S et al. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo. Antiviral Res. 2016; 127: 50-56.

  32. Mohan A. Chikungunya fever: clinical manifestations & management. Indian J Med Res. 2006; 124(5): 471-474.




2020     |     www.medigraphic.com